These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 39403928)

  • 1. Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges.
    Gold S; Shilatifard A
    J Clin Invest; 2024 Oct; 134(20):. PubMed ID: 39403928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The engagement of histone lysine methyltransferases with nucleosomes: structural basis, regulatory mechanisms, and therapeutic implications.
    Li Y; Ge K; Li T; Cai R; Chen Y
    Protein Cell; 2023 Apr; 14(3):165-179. PubMed ID: 37051671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts.
    Araki Y; Aizaki Y; Sato K; Oda H; Kurokawa R; Mimura T
    Clin Exp Rheumatol; 2018; 36(2):314-316. PubMed ID: 29465369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD1 knockdown reveals novel histone lysine methylation in human breast cancer MCF-7 cells.
    Jin Y; Huo B; Fu X; Cheng Z; Zhu J; Zhang Y; Hao T; Hu X
    Biomed Pharmacother; 2017 Aug; 92():896-904. PubMed ID: 28601046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the impact of gene variants on histone lysine methylation.
    Van Rechem C; Whetstine JR
    Biochim Biophys Acta; 2014 Dec; 1839(12):1463-76. PubMed ID: 24859469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the activity of histone lysine methyltransferases and demethylases by curcumin analog in leukaemia cells.
    Sawesi S; Malkaram SA; Abd Elmageed ZY; Fandy TE
    J Cell Mol Med; 2022 Nov; 26(22):5624-5633. PubMed ID: 36300880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoepigenomics: making histone lysine methylation count.
    Decarlo D; Hadden MK
    Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication.
    Chakravarty S; Jhelum P; Bhat UA; Rajan WD; Maitra S; Pathak SS; Patel AB; Kumar A
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):152-164. PubMed ID: 27664837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.
    Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM
    Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epigenetic enzymes for autism treatment.
    Yan Z
    Trends Pharmacol Sci; 2024 Sep; 45(9):764-767. PubMed ID: 39034229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
    Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
    ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative SET-domain methyltransferases in
    Sawant M; Benamrouz-Vanneste S; Meloni D; Gantois N; Even G; Guyot K; Creusy C; Duval E; Wintjens R; Weitzman JB; Chabe M; Viscogliosi E; Certad G
    Virulence; 2022 Dec; 13(1):1632-1650. PubMed ID: 36097362
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
    Krishnan S; Horowitz S; Trievel RC
    Chembiochem; 2011 Jan; 12(2):254-63. PubMed ID: 21243713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.